Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/ALZAMEND-NEURO-INC-123731313/news/Alzamend-Neuro-Inc-kundigt-die-Einleitung-einer-Phase-I-Iia-Studie-fur-seinen-Immuntherapie-Impf-43422658/?utm_source=whatsapp&utm_medium=social&utm_campaign=share